Stereotactic body radiotherapy for localized prostate cancer – 5-year efficacy results

BACKGROUND: The use of stereotactic body radiotherapy (SBRT) as the primary treatment modality in clinically localized prostate cancer (PCa) is emerging. The aim of the study was to analyze the long-term results of PCa patients treated with SBRT. METHODS: This non-selected, real-life patient cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Vuolukka, Kristiina, Auvinen, Päivi, Tiainen, Erno, Palmgren, Jan-Erik, Heikkilä, Janne, Seppälä, Jan, Aaltomaa, Sirpa, Kataja, Vesa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362647/
https://www.ncbi.nlm.nih.gov/pubmed/32664981
http://dx.doi.org/10.1186/s13014-020-01608-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7362647/
https://www.ncbi.nlm.nih.gov/pubmed/32664981
http://dx.doi.org/10.1186/s13014-020-01608-1

Ejemplares similares